Suchergebnisse - (Person:"Liu, Geoffrey")

PubPharm (7)

1

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Drilon, A. | Camidge, D. | Lin, J. | +131

2

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2023

von Wakelee, H. | Liberman, M. | Kato, T. | +117

CommentIn: Transl Lung Cancer Res. 2023 Nov 30;12(11):2359-2365. - PMID 38090512

3

First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

enthalten in: The New England journal of medicine | 2020

von Shaw, A. | Bauer, T. | de Marinis, F. | +112

CommentIn: Nat Rev Clin Oncol. 2021 Jan;18(1):6. - PMID 33262501

4

Ceritinib in ALK-rearranged non-small-cell lung cancer

enthalten in: The New England journal of medicine | 2014

von Shaw, A. | Kim, D. | Mehra, R. | +18

CommentIn: N Engl J Med. 2014 Mar 27;370(13):1250-1. - PMID 24670172

5

Ceritinib in ALK-rearranged non-small-cell lung cancer

enthalten in: The New England journal of medicine | 2014 March 27

von Shaw, A. | Kim, D. | Mehra, R. | +18

6

Probability of cancer in pulmonary nodules detected on first screening CT

enthalten in: The New England journal of medicine | 2013

von McWilliams, A. | Tammemagi, M. | Mayo, J. | +30

CommentIn: N Engl J Med. 2013 Nov 21;369(21):2060-1. - PMID 24256386

7

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma

enthalten in: The New England journal of medicine | 2012

von Pass, H. | Levin, S. | Harbut, M. | +13

ErratumIn: N Engl J Med. 2012 Nov;367(18):1768

1
[1]